ROCHE PRODUCTS INDIA PRIVATE LIMITED

ROCHE PRODUCTS INDIA PRIVATE LIMITED is primarily a manufacturer of pharmaceutical products. It also engages in the trading and distribution of its pharmaceutical portfolio within India.

Company Introduction:

ROCHE PRODUCTS INDIA PRIVATE LIMITED is the Indian subsidiary of F. Hoffmann-La Roche AG, a global pioneer in pharmaceuticals and diagnostics. Established to serve the healthcare needs of India, the company is dedicated to developing and providing innovative medical solutions that significantly improve the lives of patients.

Key Focus Areas:

Roche India concentrates on several critical therapeutic areas, including oncology (cancer treatment), immunology, infectious diseases, ophthalmology, and neuroscience. The company brings cutting-edge research and development from its global parent into the Indian market, aiming to address unmet medical needs and advance healthcare standards.

Operations:

The company's operations in India encompass the manufacturing of certain pharmaceutical products, as well as the marketing, sales, and distribution of its extensive range of innovative medicines and diagnostic solutions. Roche India is committed to ensuring patient access to its advanced therapies and fostering healthcare innovation within the country.

Mission:

Roche Products India Private Limited operates with the mission to improve patient lives through science, delivering high-quality, effective, and safe pharmaceutical products to the Indian populace, while adhering to the highest ethical and quality standards.

ROCHE PRODUCTS INDIA PRIVATE LIMITED manufactures and/or markets products in the following therapeutic areas:

* **Diabetes Care:** Accu-Chek range of blood glucose monitoring systems and related products.

* **Pharmaceuticals:** A range of prescription medicines across various therapeutic areas including oncology, virology, and transplantation.

* **In-vitro Diagnostics:** A wide array of diagnostic solutions for clinical chemistry, immunochemistry, molecular diagnostics, and point-of-care testing.